Cahill Represents Financing Sources in Novolex’s $6.7 Billion Take Private of Pactiv Evergreen
Date: 12/09/24
Cahill is representing the financing sources in Novolex’s $6.7 billion acquisition of Pactiv Evergreen.
This transaction is supported by Apollo, the majority shareholder of Novolex, and Canada Pension Plan Investment Board, which is contributing $1 billion and will become a significant minority shareholder in the post-merger company. Upon completion of the transaction, Pactiv Evergreen will become a privately held company and its common stock will no longer be listed on Nasdaq.
In the year-to-date, Cahill has advised top investment banks on 45 M&A-related North American loans that closed with an aggregate value of $32 billion, resulting in a #1 market share of 19+%.*
Led by partners Adam Dworkin, Ariel Goldman, Patrick Gordon, and Tristan Manley; counsel Nathalia Osorio; and associates Keith Marantz, Robert Timby, Niccolo Premutico, and Brendan Finnerty, our team helped the client successfully navigate the numerous market-related complexities inherent to take-private transactions.
*Debtwire as of December 9, 2024